Seeking Alpha

Seeking Alpha Portfolio App for iPad

671 people get UTHR articles and Market Currents by email alert.

Get email alerts on UTHR »

UTHR

United Therapeutics Corporation

5/25/2013, 2:50 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, April 25, 3:46 PM United Therapeutics (UTHR -3%) slides after its Q1 EPS results missed Street expectations earlier today. Revenue increased by nearly $41M over the prior year the period, with growth in product revenues reflecting the continuing increase in the number of patients being treated, but expenses in both R&D and SG&A pressured bottom line performance. Comment! [Healthcare, Earnings, On the Move]
Thursday, April 25, 6:10 AM United Therapeutics (UTHR): Q1 EPS of $1.19 misses by $0.28. Revenue of $245.1M beats by $3.96M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 11, 11:15 AM United Therapeutics (UTHR +0.1%) says it's received approval to perform a human Phase I study in Australia using Pluristem Therapeutics' (PSTI +1.6%) PLacental eXpanded cells in patients diagnosed with Pulmonary Arterial Hypertension. United Therapeutics and Pluristem entered into a licensing agreement in 2011 that allows UTHR to develop, market and sell PSTI's PLX-PAD cells. 1 Comment [Healthcare, On the Move]
Monday, March 25, 9:10 AM Premarket gainers: ZAZA +21%. ARWR +14%. APOL +9%. TSRX +5%. Losers: IDIX -10%. OTT -10%. UTHR -7%. PGTI -6%. Comment! [On the Move]
Monday, March 25, 6:11 AM The FDA has again rejected United Therapeutics' (UTHR) Treprostinil oral treatment for treating for high blood pressure. United Therapeutics intends to immediately request an "end of review" meeting with the FDA to discuss the rejection. Shares -6.3% premarket. (previous) (PR) Comment! [On the Move, Healthcare]
Tuesday, February 26, 1:26 PM After a valliant fight, United Therapeutics (UTHR -0.9%) gives up the days gains to trade in the red after Brean Murray cuts the shares to Hold on the back of its Q4 results posted earlier. The stock has had a good run since plummeting in October of last year on the FDA's rejection of Treprostinil, gaining nearly 30% and presently testing a 2-year high. Comment! [Healthcare, On the Move]
Tuesday, February 26, 12:22 PM United Therapeutics (UTHR +0.3%) holds on to gains in a weak tape after reporting Q4 earnings that easily beat Street estimates this morning. Revenue increased across all product lines covering both chronic and life-threatening conditions. Gross margins declined to 84% from 87% however, largely due to inventory writedowns. The company reaffirms FY13 guidance bracketing estimates, expecting revenues to fall within a range of 5% above or below $1B. Analysts are looking for revenues of $993.85M. Comment! [Healthcare, Earnings]
Tuesday, February 26, 6:11 AM United Therapeutics (UTHR): Q4 EPS of $1.60 beats by $0.36. Revenue of $243.8M beats by $10.39M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, February 26, 12:05 AM Notable earnings before Tuesday’s open: AG, AKRX, AMED, AMT, AUXL, AZO, BMO, BYD, CBRL, CIE, CMLP, CRZO, ECL, EXPD, GTI, HD, HFC, M,MFA, PCS, RRD, RSH, SKS, SPRD, SRE, THC, TSL, UNFI, UTHR Comment! [Earnings]
Monday, February 25, 5:30 PM Notable earnings before Tuesday’s open: AG, AKRX, AMED, AMT, AUXL, AZO, BMO, BYD, CBRL, CIE, CMLP, CRZO, ECL, EXPD, GTI, HD, HFC, M,MFA, PCS, RRD, RSH, SKS, SPRD, SRE, THC, TSL, UNFI, UTHR Comment! [Earnings]
Thursday, February 14, 12:05 AM Notable earnings before Thursday’s open: ABB, ABX, ALXN, ANR, APA, BGCP, BWA, CAB, CRIS, CVE, DISCA, DTV, DVA, DWRE, ECA, GELG, GM, GNC, GNRC, INCY, JAH, LNT, LUFK, MFA, NGLS, NRF, O, OAK, PDS, PEP, PPL, REGN, SHPG, STRA, TAP, UTHR, VMC, WM, ZIP Comment! [Earnings]
Wednesday, February 13, 5:30 PM Notable earnings before Thursday’s open: ABB, ABX, ALXN, ANR, APA, BGCP, BWA, CAB, CRIS, CVE, DISCA, DTV, DVA, DWRE, ECA, GELG, GM, GNC, GNRC, INCY, JAH, LNT, LUFK, MFA, NGLS, NRF, O, OAK, PDS, PEP, PPL, REGN, SHPG, STRA, TAP, UTHR, VMC, WM, ZIP Comment! [Earnings]
Tuesday, February 12, 12:05 AM Notable earnings before Tuesday’s open: AB, AVP, DBD, FIS, FOSL, GT, HCP, HERO, HUN, KO, KORS, LVLT, MHP, MMC, OHI, OMC, RAI, SPR, TGH, TRP, UTHR, VAL, VNDA Comment! [Earnings]
Monday, February 11, 5:30 PM Notable earnings before Tuesday’s open: AB, AVP, DBD, FIS, FOSL, GT, HCP, HERO, HUN, KO, KORS, LVLT, MHP, MMC, OHI, OMC, RAI, SPR, TGH, TRP, UTHR, VAL, VNDA Comment! [Earnings]
Monday, February 4, 11:17 AM United Therapeutics (UTHR +1.3%) moves up after its board authorizes an additional $420M to its existing share repurchase program. The program will become effective on March 4 and remain open for up to one year. Separately, Standpoint Research ups the shares from Hold to Buy. Comment! [Healthcare, On the Move]
Wednesday, November 21, 2012, 5:16 PM The market is well-staged right now for gains in a number of sectors, says Sabrient Systems Chief Market Strategist David Brown. Health-care companies, the energy sector, housing businesses and airlines all can be purchased at reasonable prices now with solid growth prospects well into 2013. Despite market valuations being at reasonable levels relative to historic norms, there clearly are some bargains out there. His picks: United Therapeutics (UTHR), Marathon Petroleum (MPC), US Airways (LCC) and Delta (DAL). 3 Comments [U.S. Economy]